These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

298 related articles for article (PubMed ID: 29385381)

  • 21. Competency, board certification, credentialing, and specialization: who benefits?
    Gourley DR; Fitzgerald WL; Davis RL
    Am J Manag Care; 1997 May; 3(5):795-801; quiz 805-7. PubMed ID: 10169540
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Compounding pharmacies: before and after an inspection.
    Kulkarni D; Ricketts S
    Int J Pharm Compd; 2013; 17(5):358-62. PubMed ID: 24459779
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pharmacy technician-to-pharmacist ratios: a state-driven safety and quality decision.
    Bess DT; Carter J; DeLoach L; White CL
    J Am Pharm Assoc (2003); 2014; 54(6):648-51. PubMed ID: 25343210
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prevalence of compounding in independent community pharmacy practice.
    McPherson TB; Fontane PE; Jackson KD; Martin KS; Berry T; Chereson R; Bilger R
    J Am Pharm Assoc (2003); 2006; 46(5):568-73. PubMed ID: 17036642
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Compounding practices in Iran.
    Goodarzi N; Niknam S; Akbarzadeh T; Gholami K
    Int J Pharm Compd; 2014; 18(2):112-6. PubMed ID: 24881113
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The International Academy of Compounding Pharmacists: Government Affairs Lookback on 2017 Accomplishments and Look Ahead at 2018 Initiatives.
    Blankenship C
    Int J Pharm Compd; 2018; 22(1):26-28. PubMed ID: 29385383
    [No Abstract]   [Full Text] [Related]  

  • 27. Certification of sterile equipment and facilities: what pharmacists need to know.
    Lanze A; Rudner S
    Int J Pharm Compd; 2014; 18(5):397-9. PubMed ID: 25577889
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Basics of Sterile Compounding: Personnel Requirements for Sterile Compounding.
    Akers MJ
    Int J Pharm Compd; 2016; 20(4):307-314. PubMed ID: 28333676
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Scope of contemporary pharmacy practice: roles, responsibilities, and functions of pharmacists and pharmacy technicians.
    ; Albanese NP; Rouse MJ
    J Am Pharm Assoc (2003); 2010 Mar-Apr 1; 50(2):e35-69. PubMed ID: 20199947
    [TBL] [Abstract][Full Text] [Related]  

  • 30. On accreditation of healthcare organizations. Determining eligibility for Accreditation of Home Pharmaceutical Services.
    Rich DS
    Home Care Provid; 1996; 1(3):164-6. PubMed ID: 9216271
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Updating the pharmacy technician certification examination: a practice analysis study.
    Muenzen PM; Corrigan MM; Smith MA; Rodrigue PG
    J Am Pharm Assoc (2003); 2006; 46(1):e1-6. PubMed ID: 17517579
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Obtaining accreditation by the pharmacy compounding accreditation board, part 3: developing a program of qualtity assurance and continuous qualtiy improvement.
    Cabaleiro J
    Int J Pharm Compd; 2008; 12(3):234-6. PubMed ID: 23969712
    [TBL] [Abstract][Full Text] [Related]  

  • 33. U.S. Food and Drug Administration List of Drugs NOT to be Used in Compounded Medications for Humans (The Negative List).
    Int J Pharm Compd; 2016; 20(6):457-458. PubMed ID: 28339383
    [No Abstract]   [Full Text] [Related]  

  • 34. Distinguishing between compounding facilities and the development of the 503B bulk drug substance list.
    Gianturco SL; Mattingly AN
    J Am Pharm Assoc (2003); 2021; 61(1):e8-e11. PubMed ID: 32713748
    [TBL] [Abstract][Full Text] [Related]  

  • 35. "Double, double, toil and trouble': for modern practitioners of compounding, standards and training are critical [interview by Lisa Santandrea].
    Allen LV
    Am J Nurs; 2003 May; 103(5):83. PubMed ID: 12762333
    [No Abstract]   [Full Text] [Related]  

  • 36. Drug shortages and training.
    Gumpper KF
    JPEN J Parenter Enteral Nutr; 2012 Mar; 36(2 Suppl):42S-43S. PubMed ID: 22301327
    [No Abstract]   [Full Text] [Related]  

  • 37. Explanations and unresolved issues pertaining to the development of the Nuclear Pharmacy Compounding Guidelines.
    Hung JC; Augustine SC; Cheng KT; Green RL; Hopkins WM; Laven DL; Nelson BR; Petry NA; Ponto JA; Quinton TM; Swanson DP
    J Am Pharm Assoc (Wash); 2002; 42(5):789-98. PubMed ID: 12269713
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The "Lists": What Do They Mean?
    Voliva J
    Int J Pharm Compd; 2016; 20(6):477-479. PubMed ID: 28339386
    [No Abstract]   [Full Text] [Related]  

  • 39. Warranties of a compounding pharmacist.
    Brushwood DB; Smith WT
    Am J Health Syst Pharm; 2009 Mar; 66(5):495-8. PubMed ID: 19233998
    [No Abstract]   [Full Text] [Related]  

  • 40. International Academy of Compounding Pharmacists' recommendations for state-based legislative and regulatory initiatives.
    Miller DG
    Int J Pharm Compd; 2013; 17(1):48-9. PubMed ID: 23627246
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.